| Xometry, Inc. and Subsidiaries | |||||||
| Unaudited Condensed Consolidated Statements of Cash Flows | |||||||
| (In thousands) | |||||||
| Three Months Ended March 31, | |||||||
| 2023 | 2022 | ||||||
| Cash flows from operating activities: | (unaudited) | ||||||
| Net loss | $ | (18,343 | ) | $ | (19,995 | ) | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
| Depreciation and amortization | 2,566 | 1,799 | |||||
| Impairment of assets | 27 | — | |||||
| Reduction in carrying amount of right-of-use asset | 1,935 | 1,765 | |||||
| Stock based compensation | 4,694 | 3,456 | |||||
| Revaluation of contingent consideration | — | 434 | |||||
| Income from unconsolidated joint venture | (66 | ) | (34 | ) | |||
| Donation of common stock | 370 | — | |||||
| Unrealized loss on marketable securities | — | 858 | |||||
| Non-cash income tax benefit | — | (559 | ) | ||||
| Loss on sale of property and equipment | 91 | 71 | |||||
| Amortization of deferred costs on convertible notes | 466 | 312 | |||||
| Deferred taxes benefit | (23 | ) | (2 | ) | |||
| Changes in other assets and liabilities: | |||||||
| Accounts receivable, net | (2,804 | ) | (6,145 | ) | |||
| Inventory | 133 | (180 | ) | ||||
| Prepaid expenses | 185 | 567 | |||||
| Other assets | (3,687 | ) | (1,787 | ) | |||
| Accounts payable | (503 | ) | (2,752 | ) | |||
| Accrued expenses | (2,119 | ) | (2,843 | ) | |||
| Contract liabilities | 1,436 | 2,145 | |||||
| Lease liabilities | (970 | ) | (1,369 | ) | |||
| Income taxes payable | 157 | — | |||||
| Net cash used in operating activities | (16,455 | ) | (24,259 | ) | |||
| Cash flows from investing activities: | |||||||
| Purchase of marketable securities | (2,688 | ) | (280,091 | ) | |||
| Proceeds from sale of marketable securities | — | 4 | |||||
| Purchases of property and equipment | (4,186 | ) | (2,543 | ) | |||
| Proceeds from sale of property and equipment | 223 | 165 | |||||
| Cash paid for business combination, net of cash acquired | (3,349 | ) | — | ||||
| Net cash used in investing activities | (10,000 | ) | (282,465 | ) | |||
| Cash flows from financing activities: | |||||||
| Proceeds from stock options exercised | 483 | 1,263 | |||||
| Proceeds from issuance of convertible notes | — | 287,500 | |||||
| Costs incurred in connection with issuance of convertible notes | — | (9,301 | ) | ||||
| Payments on finance lease obligations | — | (2 | ) | ||||
| Net cash provided by financing activities | 483 | 279,460 | |||||
| Effect of foreign currency translation on cash and cash equivalents | 15 | (29 | ) | ||||
| Net decrease in cash and cash equivalents | (25,957 | ) | (27,293 | ) | |||
| Cash and cash equivalents at beginning of the year | 65,662 | 86,262 | |||||
| Cash and cash equivalents at end of the period | $ | 39,705 | $ | 58,969 | |||
| Supplemental cash flow information: | |||||||
| Cash paid for interest | $ | 1,438 | $ | — | |||
| Non-cash investing and financing activities: | |||||||
| Non-cash purchase of property and equipment | 78 | — | |||||
| Non-cash consideration in connection with business combination | 1,593 | — | |||||
